Stock Research for PMCB


Featured Broker: Ally Invest

Get the due diligence for another stock.


PMCB Stock Chart & Research Data

The PMCB chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the PMCB chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


PMCB Due diligence Resources & Stock Charts

The PMCB stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View PMCB Detailed Price Forecast - CNN Money CNN View PMCB Detailed Summary - Google Finance
Yahoo View PMCB Detailed Summary - Yahoo! Finance Zacks View PMCB Stock Research & Analysis -

Stock Analysis

TradeIdeas View PMCB Trends & Analysis - Trade-Ideas Barrons View PMCB Major Holders - Barrons
NASDAQ View PMCB Call Transcripts - NASDAQ Seeking View PMCB Breaking News & Analysis - Seeking Alpha
Spotlight View PMCB Annual Report - OTC Report View PMCB OTC Short Report -
TradeKing View PMCB Fundamentals - TradeKing Charts View PMCB SEC Filings - Bar Chart
WSJ View Historical Prices for PMCB - The WSJ Morningstar View Performance/Total Return for PMCB - Morningstar
MarketWatch View the Analyst Estimates for PMCB - MarketWatch CNBC View the Earnings History for PMCB - CNBC
StockMarketWatch View the PMCB Earnings - StockMarketWatch MacroAxis View PMCB Buy or Sell Recommendations - MacroAxis
Bullish View the PMCB Bullish Patterns - American Bulls Short Pains View PMCB Short Pain Metrics -

Social Media Mentions

StockTwits View PMCB Stock Mentions - StockTwits PennyStocks View PMCB Stock Mentions - PennyStockTweets
Twitter View PMCB Stock Mentions - Twitter Invest Hub View PMCB Investment Forum News - Investor Hub
Yahoo View PMCB Stock Mentions - Yahoo! Message Board Seeking Alpha View PMCB Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for PMCB - Insider Cow View Insider Transactions for PMCB - Insider Cow
CNBC View PMCB Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for PMCB - OTC Markets
Yahoo View Insider Transactions for PMCB - Yahoo! Finance NASDAQ View Institutional Holdings for PMCB - NASDAQ

Stock Charts

FinViz View PMCB Stock Insight & Charts - StockCharts View PMCB Investment Charts -
BarChart View PMCB Stock Overview & Charts - BarChart Trading View View PMCB User Generated Charts - Trading View

Latest Financial News for PMCB

PharmaCyte Biotech Announces Details to Attend This Week’s Virtual Annual Meeting of Shareholders
Posted on Monday June 14, 2021

LAGUNA HILLS, Calif., Jun 14, 2021--PharmaCyte to hold virtual shareholder meeting to vote on critical propositions and update shareholders on FDA required work to lift clinical hold.

PharmaCyte Biotech Successfully Completes 1 Year Stability Study
Posted on Thursday April 01, 2021

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that it has successfully completed the twelve-months product stability testing required by the U.S. Food and Drug Administration (FDA) for its CypCaps™ final clinical trial product. This product will be used in the company’s planned clinical trial in locally advanced, inoperable pancreatic cancer upon the FDA lifting the clinical hold on PharmaCyte’s Investigational New Drug Application (IND).

PharmaCyte Biotech Begins DNA Sequence and Stability Studies in Response to FDA Requests for its Clinical Trial Product
Posted on Tuesday January 26, 2021

PharmaCyte Biotech begins DNA sequence and stability studies in response to the FDA's requests for PharmaCyte's clinical trial product.

PharmaCyte Biotech Begins Physical Testing of CypCaps in Response to FDA Recommendations for its Clinical Trial Product
Posted on Monday December 14, 2020

PharmaCyte Biotech begins testing of its clinical trial product in response to the FDA's recommendations to lift the clinical hold.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.